India Generics Makers Lower Expectations On Level Of Exports To Japan
This article was originally published in PharmAsia News
Indian makers of generic drugs are finding Japan's promising market, the world's second-largest and expected to reach $130 billion this year, may be more elusive than government had projected.
You may also be interested in...
Abbott is launching a second test to detect COVID-19. The diagnostics giant announced on 27 March the release of a rapid, point-of-care test that can deliver results within five minutes.
President Trump on 27 March finally pulled the trigger on using his powers under the Defense Production Act, forcing General Motors Co. to manufacture medical ventilators. The only thing is, GM is already doing that.
Theradaptive's “paint-like” regenerative therapeutic can be applied to any device to promote bone regrowth or regenerate tissue.